ClinicalTrials.gg

Program

VER-01

A development code.

Its studies are mostly in Low Back Pain · Radiculopathy · Chronic Pain, led by Vertanical.

Furthest: phase 3, since Jun 7, 20216 company-led studies, 1 open or runningNext primary completion: Sep 2028 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Vertanical61 open or runningphase 3since Jun 7, 2021May 24, 2021Sep 2028phase 3 · NCT06956014

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. May 24, 2021First study: phase 1 study in Marijuana AbuseFirst studyNCT04930809 · 42 enrolled · Austria
  2. Jun 7, 2021Phase 3 study in Chronic Non-specific Low Back PainNCT04940741 · 820 enrolled · Germany
  3. Jun 7, 2021Phase 1 study in Marijuana AbuseNCT04930796 · 18 enrolled · Austria
  4. Nov 2, 2022Phase 3 study in Chronic Non-specific Low Back PainNCT05610813 · 384 enrolled · Germany
  5. Jun 12, 2024Phase 2 study in Chronic PainNCT06475001 · 652 enrolled · United Kingdom
  6. Apr 24, 2025Phase 3 study in Lumbosacral RadiculopathyNCT06956014 · 810 planned · United States

Ahead

  1. Sep 2028Primary completion: phase 3 study in Lumbosacral RadiculopathyNCT06956014

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06956014Lumbosacral Radiculopathy · United States3RecruitingSep 2028810
NCT06475001Chronic Pain · United Kingdom2CompletedJul 31, 2025652
NCT05610813Chronic Non-specific Low Back Pain · Germany3CompletedOct 18, 2024384
NCT04940741Chronic Non-specific Low Back Pain · Germany3CompletedMar 26, 2024820
NCT04930796Marijuana Abuse · Austria1CompletedNov 17, 202218
NCT04930809Marijuana Abuse · Austria1CompletedJul 4, 202242

How it is read

Names in the registry

  • “VER-01”, 6 entries

Codes read as this program: VER01.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.